Northeast Pharmaceutical Group Co Ltd (000597) — Cash Flow Reinvestment Rate
Northeast Pharmaceutical Group Co Ltd (000597) has a Cash Flow Reinvestment Rate of 0.04x as of September 2025, reinvesting CN¥11.48 Million (capex CN¥11.48 Million ) from operating cash flow of CN¥274.09 Million. Check Northeast Pharmaceutical Group Co Ltd cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Northeast Pharmaceutical Group Co Ltd Cash Flow Reinvestment Rate (1999–2025)
Historical reinvestment intensity for Northeast Pharmaceutical Group Co Ltd across 23 annual periods. Explore how much of Northeast Pharmaceutical Group Co Ltd's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Northeast Pharmaceutical Group Co Ltd (1999–2025)
Year-by-year capital reinvestment analysis for Northeast Pharmaceutical Group Co Ltd. For live market cap and broader valuation context, see 000597 stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.09x | CN¥100.65 Million | CN¥1.11 Billion | CN¥97.78 Million | ▼ -84.4% |
| 2024 | 0.58x | CN¥443.39 Million | CN¥758.76 Million | CN¥159.43 Million | ▼ -26.0% |
| 2023 | 0.79x | CN¥463.40 Million | CN¥586.75 Million | CN¥235.43 Million | ▲ +74.9% |
| 2022 | 0.45x | CN¥500.47 Million | CN¥1.11 Billion | CN¥244.13 Million | ▲ +148.3% |
| 2021 | 0.18x | CN¥135.71 Million | CN¥746.51 Million | CN¥119.81 Million | ▼ -75.1% |
| 2020 | 0.73x | CN¥416.28 Million | CN¥570.92 Million | CN¥400.38 Million | ▲ +4.9% |
| 2019 | 0.70x | CN¥245.06 Million | CN¥352.60 Million | CN¥229.17 Million | ▼ -65.9% |
| 2018 | 2.04x | CN¥581.64 Million | CN¥285.09 Million | CN¥565.74 Million | ▲ +10.2% |
| 2016 | 1.85x | CN¥712.04 Million | CN¥384.51 Million | CN¥177.01 Million | ▼ -74.2% |
| 2015 | 7.18x | CN¥716.04 Million | CN¥99.70 Million | CN¥346.04 Million | ▼ -36.6% |
| 2014 | 11.33x | CN¥532.27 Million | CN¥46.99 Million | CN¥532.27 Million | ▲ +445.1% |
| 2012 | 2.08x | CN¥178.90 Million | CN¥86.09 Million | CN¥178.90 Million | ▲ +12.2% |
| 2010 | 1.85x | CN¥473.93 Million | CN¥255.96 Million | CN¥473.93 Million | ▲ +32.2% |
| 2009 | 1.40x | CN¥862.78 Million | CN¥615.91 Million | CN¥862.78 Million | ▲ +176.5% |
| 2008 | 0.51x | CN¥359.27 Million | CN¥709.03 Million | CN¥359.27 Million | ▲ +14.6% |
| 2007 | 0.44x | CN¥87.78 Million | CN¥198.56 Million | CN¥87.78 Million | ▼ -52.5% |
| 2005 | 0.93x | CN¥103.66 Million | CN¥111.40 Million | CN¥103.66 Million | ▲ +221.2% |
| 2004 | 0.29x | CN¥61.14 Million | CN¥211.06 Million | CN¥61.14 Million | ▼ -23.8% |
| 2003 | 0.38x | CN¥87.46 Million | CN¥230.08 Million | CN¥87.46 Million | ▲ +57.1% |
| 2002 | 0.24x | CN¥38.07 Million | CN¥157.41 Million | CN¥38.07 Million | ▼ -59.1% |
| 2001 | 0.59x | CN¥46.57 Million | CN¥78.84 Million | CN¥46.57 Million | ▲ +75.2% |
| 2000 | 0.34x | CN¥12.18 Million | CN¥36.13 Million | CN¥12.18 Million | ▲ +95.9% |
| 1999 | 0.17x | CN¥9.41 Million | CN¥54.62 Million | CN¥9.41 Million | — |